EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
Bev Menner and Dominic Wall
Cell Therapies
National Finalist in EY Entrepreneur Of The Year 2025 Australia
Bev Menner serves as the CEO of Cell Therapies Pty Ltd, a leader in advanced cell-based therapy manufacturing that is redefining the landscape of modern medicine. Before taking the helm in 2023, Menner playing a pivotal role in the successful delivery of the AstraZeneca COVID-19 vaccine to Australia. She is now focussed on expanding the innovative ‘living therapies’ delivered by Cell Therapies to Australians and patients across Asia Pacific. Cell therapy is at the forefront of medical innovation, often using a patient’s own immune cells to treat life-threatening conditions, including a variety of cancers.
This groundbreaking approach empowers the body to treat itself, offering transformative potential for patients and revolutionising traditional treatment paradigms. Dominic Wall, co-founder and Chief Scientific Officer, has been with Cell Therapies since its establishment in 2003. His expertise in cell and gene therapies is underscored by numerous accolades, including the Darwin Prockop Award for Mentoring and a Founding Fellowship from the Royal College of Pathologists of Australasia. Wall’s contributions have solidified his reputation as a leader in the field. Under the combined leadership of Menner and Wall, Cell Therapies Pty Ltd has emerged as a cornerstone in the delivery of these truly innovative life-saving therapies. Their commitment to innovation and excellence positions the company as a key player in the cell and gene therapy sector, with a strong focus on sustainability and transformative healthcare solutions that are poised to make a lasting impact on patient care.